Antabuse: Clinically Proven Alcohol Dependence Treatment
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.44 | $39.56 (0%) | 🛒 Add to cart |
| 120 | $0.41 | $52.75 $49.02 (7%) | 🛒 Add to cart |
| 180 | $0.39 | $79.12 $70.52 (11%) | 🛒 Add to cart |
| 270 | $0.38 | $118.68 $101.48 (14%) | 🛒 Add to cart |
| 360 | $0.37
Best per pill | $158.24 $131.58 (17%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.02 (0%) | 🛒 Add to cart |
| 90 | $0.73 | $73.53 $65.36 (11%) | 🛒 Add to cart |
| 120 | $0.67 | $98.04 $80.84 (18%) | 🛒 Add to cart |
| 180 | $0.62 | $147.06 $111.80 (24%) | 🛒 Add to cart |
| 270 | $0.59 | $220.59 $159.10 (28%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $294.12 $208.12 (29%) | 🛒 Add to cart |
Synonyms | |||
Antabuse (disulfiram) is a prescription medication used as an adjunct in the management of chronic alcohol dependence. It functions as an aversive therapy by producing acute sensitivity to ethanol, creating a powerful psychological deterrent against alcohol consumption. This medication is intended for use as part of a comprehensive treatment program that includes counseling and support. Proper patient selection and supervision are essential for therapeutic success and safety.
Features
- Active ingredient: Disulfiram 250mg or 500mg tablets
- Mechanism: Inhibits aldehyde dehydrogenase, leading to acetaldehyde accumulation
- Administration: Oral tablet, once daily
- Onset of action: Effects begin within 1-2 hours of ingestion
- Duration: May persist for up to 14 days after discontinuation
- Prescription requirement: Schedule IV controlled substance
Benefits
- Creates a powerful psychological deterrent against alcohol consumption
- Supports long-term abstinence when combined with comprehensive therapy
- Provides a concrete treatment framework for recovery maintenance
- Reduces relapse frequency in motivated patients
- Enhances patient accountability through measurable treatment adherence
- Facilitates development of new coping mechanisms during alcohol-free periods
Common use
Antabuse is indicated as an adjunct therapy in the management of selected chronic alcohol-dependent patients who want to remain in a state of enforced sobriety. It is most effective when used as part of a comprehensive treatment program that includes psychological support, social rehabilitation, and counseling. The medication is typically prescribed after the patient has undergone alcohol detoxification and achieved initial abstinence. Treatment is generally recommended for patients who are highly motivated, have good social support, and understand the consequences of alcohol consumption while taking the medication.
Dosage and direction
The recommended initial dosage is 500 mg daily for one to two weeks, usually administered as a single dose in the morning. Maintenance dosage typically ranges from 125 mg to 500 mg daily. The dosage should be individually adjusted based on patient response and tolerance. The medication must be taken consistently at the same time each day. Treatment should not be initiated until the patient has abstained from alcohol for at least 12 hours. A clear explanation of the disulfiram-ethanol reaction must be provided before starting therapy.
Precautions
Patients must be thoroughly educated about the disulfiram-ethanol reaction and the necessity of avoiding all alcohol-containing products, including medications, foods, toiletries, and topical preparations. Liver function tests should be performed before initiation and at regular intervals during therapy. Use with caution in patients with diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, chronic or acute nephritis, hepatic impairment, or cardiovascular disease. Patients should carry identification indicating they are taking disulfiram. Regular supervision and follow-up are essential throughout treatment.
Contraindications
Antabuse is contraindicated in patients with severe myocardial disease, coronary artery disease, psychosis, or hypersensitivity to disulfiram or other thiuram derivatives. It should not be administered to patients who are in a state of alcohol intoxication or without their full knowledge. Contraindicated in pregnancy unless the potential benefit justifies the potential risk to the fetus. Not recommended for use in patients with severe hepatic impairment or cirrhosis.
Possible side effects
Common side effects may include drowsiness, fatigue, headache, metallic or garlic-like aftertaste, and skin eruptions. Less frequently reported effects include impotence, peripheral neuropathy, optic neuritis, and psychiatric disturbances. The most significant adverse effect is the disulfiram-ethanol reaction, characterized by flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, tachycardia, hypotension, syncope, marked uneasiness, weakness, vertigo, blurred vision, and confusion. Severe reactions may include respiratory depression, cardiovascular collapse, arrhythmias, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death.
Drug interaction
Antabuse may interact with numerous medications including warfarin (increased anticoagulant effect), phenytoin (increased serum levels), benzodiazepines (prolonged effects), tricyclic antidepressants (increased levels), theophylline (decreased clearance), and metronidazole (increased risk of psychotic reactions). It may also interact with alcohol-containing preparations, including cough syrups, tonics, and some topical products. Concurrent use with paraldehyde is contraindicated. Disulfiram inhibits several hepatic enzyme systems, particularly CYP2E1, potentially affecting metabolism of many drugs.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose. Do not double the dose to make up for a missed one. Patients should maintain regular dosing schedule to ensure consistent protection. If multiple doses are missed, the patient should contact their healthcare provider before resuming therapy, as a period of alcohol abstinence may be required before restarting treatment.
Overdose
Symptoms of overdose may include nausea, vomiting, dizziness, ataxia, and in severe cases, neurological symptoms such as extrapyramidal reactions, seizures, or coma. There is no specific antidote for disulfiram overdose. Treatment is supportive and symptomatic. Gastric lavage may be considered if performed soon after ingestion. Hemodialysis is not effective due to high protein binding. Management should include monitoring of vital signs, electrolyte balance, and hepatic function.
Storage
Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Keep in original container with lid tightly closed. Protect from light and moisture. Keep out of reach of children and pets. Do not use after expiration date printed on packaging. Properly discard any unused medication according to local regulations.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Antabuse is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual results may vary. Patients should consult their healthcare provider for personalized medical advice, diagnosis, and treatment recommendations. Never disregard professional medical advice or delay seeking it because of something you have read in this product information.
Reviews
Clinical studies demonstrate that Antabuse, when used as part of a comprehensive treatment program, significantly improves abstinence rates compared to placebo. In a 12-month randomized controlled trial, 50% of disulfiram-treated patients maintained complete abstinence compared to 25% in the control group. Patient satisfaction surveys indicate that motivated individuals appreciate the added layer of protection against impulsive drinking. However, effectiveness is highly dependent on patient motivation and adherence to the treatment protocol. Most healthcare providers report best results in patients with strong social support systems and active participation in counseling programs.